{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:34:39Z","timestamp":1764603279548},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dmidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.diagmicrobio.2014.05.021","type":"journal-article","created":{"date-parts":[[2014,6,5]],"date-time":"2014-06-05T19:43:36Z","timestamp":1401997416000},"page":"34-40","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Sentinel surveillance of invasive candidiasis in Spain: epidemiology and antifungal susceptibility"],"prefix":"10.1016","volume":"81","author":[{"given":"M.C.","family":"Nieto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Teller\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Cisterna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2014.05.021_bb0005","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1128\/JCM.43.4.1829-1835.2005","article-title":"Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population- based surveillance, Barcelona, Spain, from 2002 to 2003","volume":"43","author":"Almirante","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2014.05.021_bb0010","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s10096-003-0890-x","article-title":"Candidemia at a tertiary care hospital: epidemiology and factors influencing mortality","volume":"22","author":"Alonso-Valle","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2014.05.021_bb0015","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/jac\/dks388","article-title":"Treatment of Candida famata bloodstream infections: case series and review of the literature","volume":"68","author":"Beyda","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2014.05.021_bb0020","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.eimc.2012.02.003","article-title":"Candidemia y candidiasis invasora en el adulto. Formas cl\u00ednicas y tratamiento","volume":"30","author":"Cervera","year":"2012","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2014.05.021_bb0025","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1128\/JCM.00920-10","article-title":"Nationwide Sentinel Surveillance of Bloodstream Candida Infections in 40 Tertiary Care Hospitals in Spain","volume":"48","author":"Cisterna","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2014.05.021_bb0030","series-title":"CLSI document MM18-A","article-title":"Interpretive Criteria for Identification of Bacteria and Fungi by DNA Target Sequencing; Approved Guideline","author":"CLSI","year":"2008"},{"key":"10.1016\/j.diagmicrobio.2014.05.021_bb0035","series-title":"CLSI document M27- S3","article-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast; Third Informational Supplement","author":"CLSI","year":"2008"},{"key":"10.1016\/j.diagmicrobio.2014.05.021_bb0040","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s10096-003-0973-8","article-title":"Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis","volume":"22","author":"Colombo","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.05.021_bb0045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2165\/11315500-000000000-00000","article-title":"Epidemiology, incidence and risk factors for invasive candidiasis in high-risk patients","volume":"69","author":"Concia","year":"2009","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2014.05.021_bb0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"M.ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2014.05.021_bb0055","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0123-9392(10)70133-8","article-title":"Candida y candidiasis invasora: un reto continuo para su diagn\u00f3stico temprano","volume":"14","author":"De Bedout","year":"2010","journal-title":"Infectio"},{"key":"10.1016\/j.diagmicrobio.2014.05.021_bb0060","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1086\/375080","article-title":"Caspofungin","volume":"36","author":"Deresinski","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2014.05.021_bb0065","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jinf.2007.10.014","article-title":"Increasing in cadence of Candida parapsilosis candidemia with caspofungin usage","volume":"56","author":"Forrest","year":"2008","journal-title":"J Infect"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2014.05.021_bb0070","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/jac\/dks271","article-title":"Epidemiology and echinocandin susceptibility of Candida parapsilosis sensu lato species isolated from bloodstream infections at a Spanish university hospital","volume":"67","author":"Garcia-Effron","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.05.021_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.medcli.2009.06.066","article-title":"Nosocomial candidemia at a general hospital: prognostic factors and impact of early empiric treatment on outcome (2002\u20132005)","volume":"134","author":"G\u00f3mez","year":"2010","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.diagmicrobio.2014.05.021_bb0080","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1086\/599039","article-title":"Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry","volume":"48","author":"Horn","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2014.05.021_bb0085","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1128\/AAC.49.9.3616-3623.2005","article-title":"Caspofungin susceptibility testing of isolates from patients with esophageal candidiasis or invasive candidiasis: relationship of MIC to treatment outcome","volume":"49","author":"Kartsonis","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2014.05.021_bb0090","doi-asserted-by":"crossref","first-page":"R253","DOI":"10.1186\/cc10514","article-title":"Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive Candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis","volume":"15","author":"Kett","year":"2011","journal-title":"Crit Care"},{"issue":"Suppl 5","key":"10.1016\/j.diagmicrobio.2014.05.021_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1469-0691.2011.03615.x","article-title":"European expert opinion on the management of invasive candidiasis in adults","volume":"17","author":"Kullberg","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2014.05.021_bb0100","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1086\/520277","article-title":"Emergence of Candida parapsilosis as the predominant species causing candidemia in children","volume":"26","author":"Levy","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.05.021_bb0105","doi-asserted-by":"crossref","first-page":"e1003079","DOI":"10.1371\/journal.ppat.1003079","article-title":"Candida and Host Determinants of Susceptibility to Invasive Candidiasis","volume":"9","author":"Lionakis","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.diagmicrobio.2014.05.021_bb0110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/315193","article-title":"Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole","volume":"181","author":"Marr","year":"2000","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.05.021_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1469-0691.2010.03448.x","article-title":"Anidulafungin for the treatment of invasive candidiasis","volume":"17","author":"Mayr","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2014.05.021_bb0120","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archinte.1962.03620240029006","article-title":"Gram-negative bacteremia: I. Etiology and ecology","volume":"110","author":"McCabe","year":"1962","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.diagmicrobio.2014.05.021_bb0125","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1128\/JCM.02434-08","article-title":"Activity of contemporary antifungal agents, including the novel echinocandin anidulafungin, tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: report from the SENTRY antimicrobial surveillance program (2006 to 2007)","volume":"47","author":"Messer","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.05.021_bb0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1469-0691.2001.00158.x","article-title":"In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species","volume":"7","author":"Moore","year":"2001","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2014.05.021_bb0135","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1128\/AAC.49.2.767-769.2005","article-title":"Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis","volume":"49","author":"Moudgal","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2014.05.021_bb0140","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1086\/655683","article-title":"Epidemiology of opportunistic fungal infections in Latin America","volume":"51","author":"Nucci","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2014.05.021_bb0145","doi-asserted-by":"crossref","first-page":"e59373","DOI":"10.1371\/journal.pone.0059373","article-title":"Epidemiology of Candidemia in Latin America: A Laboratory-Based Survey","volume":"8","author":"Nucci","year":"2013","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2014.05.021_bb0150","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1128\/AAC.47.10.3149-3154.2003","article-title":"Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States","volume":"47","author":"Ostrosky-Zeichner","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2014.05.021_bb0155","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/376906","article-title":"A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients","volume":"37","author":"Pappas","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2014.05.021_bb0160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.riam.2011.02.005","article-title":"Variaci\u00f3n de la epidemiolog\u00eda de las fungemias y de la sensibilidad al fluconazol de los aislamientos de hemocultivos en los \u00faltimos 10 a\u00f1os en Espa\u00f1a: resultados del estudio FUNGEMYCA","volume":"28","author":"Pem\u00e1n","year":"2011","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.diagmicrobio.2014.05.021_bb0165","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1517\/13543784.13.9.1183","article-title":"Anidulafungin: an echinocandin antifungal","volume":"13","author":"Pfaller","year":"2004","journal-title":"Expert Opin Investig Drugs"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.05.021_bb0170","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.05.021_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408410903241444","article-title":"Epidemiology of invasive mycoses in North America","volume":"36","author":"Pfaller","year":"2010","journal-title":"Crit Rev Microbiol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.05.021_bb0175","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/JCM.01901-07","article-title":"In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance","volume":"46","author":"Pfaller","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2014.05.021_bb0185","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.medcli.2009.09.021","article-title":"Nosocomial candidemias and invasive candidiasis","volume":"134","author":"Quind\u00f3s","year":"2010","journal-title":"Med Clin"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2014.05.021_bb0190","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.eimc.2009.04.001","article-title":"Antif\u00fangicos para uso sist\u00e9mico","volume":"27","author":"Ruiz-Camps","year":"2009","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.diagmicrobio.2014.05.021_bb0195","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10096-004-1103-y","article-title":"Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study","volume":"23","author":"Tortorano","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2014.05.021_bb0200","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1086\/514731","article-title":"Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)","volume":"28","author":"Viscoli","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2014.05.021_bb0210","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/clinids\/20.1.115","article-title":"Importance of Candida species other than C. albicans as pathogens in oncology patients","volume":"20","author":"Wingard","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2014.05.021_bb0205","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1056\/NEJM199110313251803","article-title":"Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole","volume":"325","author":"Wingard","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diagmicrobio.2014.05.021_bb0215","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1086\/496922","article-title":"The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis","volume":"41","author":"Zaoutis","year":"2005","journal-title":"Clin Infect Dis"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889314002405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889314002405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T16:39:29Z","timestamp":1597941569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889314002405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0732889314002405"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2014.05.021","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sentinel surveillance of invasive candidiasis in Spain: epidemiology and antifungal susceptibility","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2014.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}